Shukla Sanjay 4
4 · aTYR PHARMA INC · Filed Feb 21, 2023
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Shukla Sanjay
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-16+336,096→ 336,096 totalExercise: $2.19Exp: 2033-02-16→ Common Stock (336,096 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 16, 2023, such that this option will be fully exercisable on February 16, 2027. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.